product

Descriptions

HFNC (often referred to as high-flow) systems are broadly defined as systems that provide an oxygen-gas mixture at flows that meet or exceed a patient’s spontaneous inspiratory effort.

 High-flow nasal cannula (HFNC) therapy is an oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a high flow rate per minute. 

Applications

Acute hypoxic respiratory failure (ARF) was the first condition treated with HFNC in adults. The use of heated and humidified high flow nasal cannula (HFNC) has become increasingly popular in the treatment of patients with acute respiratory failure through all age groups.

HFNC has been used as a prophylactic tool or as a treatment device mostly in patients with acute hypoxemic respiratory failure such as pre-oxygenation before intubation, immunocompromised patients and acute heart failure.

Advantages

The first company to research, develop and produce high-flow in China.

 In the battle against Covid-19 in Wuhan in 2020, 70% high-flow device was from micomme.

 Built-in oxygen-gas mixture to accurately control oxygen and adjust oxygen concentration.

Temperature can be adjusted precisely.

Unique one-way airway design, no need for disinfection, reducing equipment turnover time and the workload of medical staff.

Specifications